Publications

5802 Results

Improved efficacy of carboplatin (CarboP)/cyclophosphamide (CPA)vs cisplatin (CisP)/CPA: Preliminary report of a phase III, randomizedtrial in stages III-IV, suboptimal ovarian cancer (OVCA).

Authors
D Alberts;S Green;E Hannigan;R O'Toole;N Mason-Liddil;E Surwit;D Stock-Novack;R Goldberg;V Malviya;W Nahhas
Journal / Conference
ASCO 8:151(#588)
Year
1989
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

A phase II study of 5-fluorouracil (5-FU) plus cisplatin (P) formetastatic colorectal adeno-carcinoma: A Southwest Oncology Groupstudy.

Authors
RP Whitehead;T Fleming;JS Macdonald;F Ahmann;M Inamasu
Journal / Conference
ASCO 8:128(#498)
Year
1989
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8424

Significance of pre-treatment stratification by extent of disease(ED) in stage D2 prostate cancer (PC) patients treated with leuprolide +flutamide (LF) or leuprolide + placebo (LP).

Authors
M Eisenberger;ED Crawford;B Blumenstein;R Benson;D McLeod;A Dorr;J Spaulding
Journal / Conference
ASCO 8:132(#515)
Year
1989
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8494 (INT-0036)

Phase II trial of menogaril in advanced pancreatic carcinoma:A Southwest Oncology Group trial.

Authors
T Brown;L Baker;P Goodman;T Fleming;G Fries;J Macdonald
Journal / Conference
ASCO 8:124(#481)
Year
1989
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8513

Randomized comparison of cisplatin (CDDP) + 5-fluorouracil (5-FU)vs. carboplatin (CBP) + 5-FU vs. methotrexate (MTX) in advanced squamouscell carcinoma of the head and neck.

Authors
A Forastiere;B Metch;M Keppen;D Schuller;J Ensley;C Coltman, Jr
Journal / Conference
ASCO 8:168(#655)
Year
1989
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8514

Analysis of treatment failure in acute non-lymphocytic leukemia(ANLL) patients over fifty years of age: A Southwest Oncology Group(SWOG) study.

Authors
D Ryan;M Grever;K Kopecky
Journal / Conference
ASCO 8:206(#800)
Year
1989
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8522

A phase II study of menogaril (NSC 269148) in colorectalcarcinoma: A Southwest Oncology Group study.

Authors
RP Whitehead;RH Earhart;P Goodman;JS Macdonald;T Pollock;JS Ungerleider
Journal / Conference
ASCO 8:117(#453)
Year
1989
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8565

A phase II study of IV bolus recombinant interleukin 2 (IL-2) inmetastatic malignant melanoma: A Southwest Oncology Group study

Authors
RP Whitehead;KJ Kopecky;MK Samson;JJ Costanzi;R Natale;L Feun;EM Hersh
Journal / Conference
ASCO 8:284(#1108)
Year
1989
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8569

Biological parameters associated with therapeuticnon-responsiveness in a cute myeloid leukemia (AML).

Authors
C Willman;L Elias;B Griffith;L Dressler;E Erickson-Ford;D Head;K Kopecky;D Stock-Novack;J Weick;M Grever
Journal / Conference
ASCO 8:200(#777)
Year
1989
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

Phase II evaluation of recombinant interleukin-2 rIL-2) inmetastatic renal cell carcinoma (RCC):SWOG-8617

Authors
RM Bukowski;P Goodman;ED Crawford;JS Sergi;L Baker;J Neidhart
Journal / Conference
ASCO 8:143(#556)
Year
1989
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8617